Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker

As of 2026-09-18, the Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker is open. You can check whether you qualify with the free 1-minute eligibility self-check below.

Last verified: 2026-09-18

Am I eligible for the Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker?

New study linking gabapentin to dementia may open door to litigation over the painkiller's side effects.

How do I join the Gabapentin Dementia Risks May Result in Lawsuits Against Drug Maker?

1. Run the free 1-minute eligibility self-check.
2. If you qualify, register your claim on the platform.
3. Class members typically pay nothing unless money is recovered.

Other active class actions

• Inferior Vena Cava IVC Filter Class Action
• Johnson and Johnson Ovarian Cancer Class Action
• 911 Fees Class Action
• Barrick Pascua-Lama Class Action
• Bernzomatic Gas Torch Defect Class Action
• Canadian Standards Association/Standards Council of Canada Class Actio
• Chevy & Cadillac Defective Transmissions – GM Class Action Canada
• Chrysler Ignition Class Action
• Dodge Chrysler Tire Sensor Defect Class Action
• Eliquis Class Action
• Essure Permanent Birth Control Class Action
• Fiat Chrysler Diesel Emissions Class Action

← Browse all 3724+ class actions

This is a free eligibility self-check, not a law firm, not legal advice, and not a lawyer referral service. Using it does not create a lawyer-client relationship.